SeeNext Venture is recalling approximately 8,000 units of NumbSkin pain relief cream with 5% lidocaine. The product's packaging is not child-resistant as required by law, which poses a serious poisoning risk if a young child accesses and ingests or applies the cream to their skin. The affected cream was sold in 30-gram white tubes with blue accents exclusively on Amazon.com between October 2019 and February 2020. Consumers should immediately move the product to a secure location and contact the company for a free replacement.
The packaging lacks a child-resistant cap, allowing young children to easily open the tube. This creates a risk of lidocaine poisoning if the cream is ingested or absorbed through the skin in large amounts.
Consumers should immediately store the pain relief cream in a safe location out of reach of children and contact SeeNext Venture for instructions on how to dispose or return it and to receive a free replacement similar product with a child-resistant cap. Amazon is contacting all known purchasers directly.
Recalled NumbSkin pain relief cream
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: CPSC Notice · Raw API Response